Vying to best bigger rivals in Parkinson’s, Neuron23 nabs $100M to reach clinic

 
Parkinson’s disease research has revealed insights into a particular protein that is now a hot target, drawing hundreds of millions of dollars in investment to support the research of drugs intended to stop it. Scientists at Neuron23 believe that their drug candidate can be the best in…

Source: medcitynews.com – Read more